NGF promotes microglial migration through the activation of its high affinity receptor:: Modulation by TGF-β

被引:49
作者
De Simone, R. [1 ]
Ambrosini, E. [1 ]
Carnevale, D. [1 ]
Ajmone-Cat, M. A. [1 ]
Minghetti, L. [1 ]
机构
[1] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Degenerat Inflammatory & Neurol Dis, I-00161 Rome, Italy
关键词
microglia; inflammation; cell migration; neuroprotection;
D O I
10.1016/j.jneuroim.2007.07.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation and mobilization of microglia are early events in the majority of brain pathologies. Among the signalling molecules that can affect microglial behaviour, we investigated whether nerve growth factor (NGF) was able to influence microglial motility. We found that NGF induced chemotaxis of microglial cells through the activation of TrkA receptor. In addition, NGF chemotactic activity was increased in the presence of low concentrations (<= 0.2 ng/ml) of transforming growth factor-beta (TGF-beta), which at this concentration showed chemotactic activity per se. On the contrary, NGF-induced microglial migration was reduced in the presence of chemokinetic concentration of TGF-beta (>= 2 ng/ml). Finally, both basal and NGF-induced migratory activity of microglial cells was increased after a long-term exposure of primary mixed glial cultures to 2 ng/ml of TGF-beta. Our observations suggest that both NGF and TGF-beta contribute to microglial recruitment. The chemotactic activities of these two pleiotropic factors could be particularly relevant during chronic diseases in which recruited microglia remove apoptotic neurons in the absence of a typical inflammatory reaction. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 58 条
[51]   Microglia and neuroprotection: implications for Alzheimer's disease [J].
Streit, WJ .
BRAIN RESEARCH REVIEWS, 2005, 48 (02) :234-239
[52]  
Tabakman R, 2004, PROG BRAIN RES, V146, P387
[53]   Functions of transforming growth factor-β isoforms in the nervous system -: Cues based on localization and experimental in vitro and in vivo evidence [J].
Unsicker, K ;
Strelau, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (24) :6972-6975
[54]   Alzheimer's disease and angiogenesis [J].
Vagnucci, AH ;
Li, WW .
LANCET, 2003, 361 (9357) :605-608
[55]   Enhanced expression of NGF receptors in multiple sclerosis lesions [J].
Valdo, P ;
Stegagno, C ;
Mazzucco, S ;
Zuliani, E ;
Zanusso, G ;
Moretto, G ;
Raine, CS ;
Bonetti, B .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (01) :91-98
[56]   TGF beta 1 and TGF beta 2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid [J].
Vawter, MP ;
DillonCarter, O ;
Tourtellotte, WW ;
Carvey, P ;
Freed, WJ .
EXPERIMENTAL NEUROLOGY, 1996, 142 (02) :313-322
[57]   Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system [J].
Villoslada, P ;
Hauser, SL ;
Bartke, I ;
Unger, J ;
Heald, N ;
Rosenberg, D ;
Cheung, SW ;
Mobley, WC ;
Fisher, S ;
Genain, CP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (10) :1799-1806
[58]   Neuroprotection by transforming growth factor-β1 involves activation of nuclear factor-κB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways [J].
Zhu, Y ;
Culmsee, C ;
Klumpp, S ;
Krieglstein, J .
NEUROSCIENCE, 2004, 123 (04) :897-906